Michael Fahey

Projects

Projects per year 2007 2013 2018 2019 2021 2026

• 12 Active
• 15 Finished

Projects per year

Search results

• Active

  A Phase I/II Open-Label Study to Evaluate the Safety and Efficacy of Orally Administered Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (FEN164) in Children with Autism Spectrum Disorder.

  Fahey, M.

  27/10/21 → 26/11/26

  Project: Research

• Genomics Research Fellow in CP

  Fahey, M. & Hunt, R.

  1/07/21 → 30/06/22

  Project: Research

• GAnaxolone In Neonatal SeizureS

  Hunt, R., Yawno-Fegan, T., Miller, S. & Fahey, M.

  1/06/21 → 30/05/24

  Project: Research

• School Readiness child outcomes of early neuroprotection/ early neurorehabilitation for infants at high risk of Cerebral Palsy- in the first 2,000 days

  Boyd, R. N., Novak, I., Morgan, C., Sakzewski, L., Fahey, M., Ware, R. S., Comans, T. A., Whittingham, K., Trost, S. G., Pannek, K. & Palmer, K.

  1/06/21 → 31/05/25

  Project: Research

• A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 as an Adjunctive Therapy in Pediatric Patients with Developmental and/or Epileptic Encephalopathies

  Fahey, M.

  14/01/20 → 13/01/25

  Project: Research

• PROTECT Me: Assessing Antenatal Maternal Melatonin Supplementation in Fetal Growth Restriction to Improve Neurodevelopmental Outcomes

  Palmer, K., Wallace, E., Groom, K., Mol, B., Davies, M., Fahey, M., Anderson, P., Goergen, S., Pannek, K. & Miller, S.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/20 → 31/12/25

  Project: Research

• A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients with Rare Epilepsy (ENDYMION)

  Fahey, M.

  8/10/19 → 7/10/24

  Project: Research

• A Double-blind, Randomize, Placebo-controlled Trial of Adjunctive Ganaxolone Treatment in Children and Young Adults with Cyclindependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) Followed by Long-term Open-label Treatment

  Fahey, M.

  14/08/19 → 13/08/24

  Project: Research

• MRI guided-focused ultrasound: a novel delivery system for neural stem cells to repair the injured neonatal brain

  McDonald, C., Fahey, M., Jenkin, G., Novak, I., Miller, S., De Veer, M., Finch-Edmondson, M. L., Snyder, E. & Wallace, E.

  Cerebral Palsy Alliance

  1/06/19 → 31/05/22

  Project: Research

• Targeted stem cell therapy for inflammation-induced preterm brain injury

  McDonald, C., Fahey, M., Castillo Melendez, M. E., Miller, S., Jenkin, G. & Yawno-Fegan, T.

  Cerebral Palsy Alliance

  1/06/19 → 30/06/22

  Project: Research

• Using Zebra Fish to Model Genetic Causes of Cerebral Palsy

  Fahey, M., Kaslin, J. & Kruer, M. C.

  Cerebral Palsy Alliance

  1/06/19 → 30/05/22

  Project: Research

• Antenatal melatonin to provide neuroprotection to the growth restricted fetus.

  Wallace, E., Palmer, K., Miller, S., Anderson, P. & Fahey, M.

  1/07/18 → 31/12/22

  Project: Research